CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.51 CNY | +5.58% |
|
+8.45% | -20.86% |
| Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
| Apr. 02 | Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.86% | 3.5B | |
| +4.99% | 25.92B | |
| +9.57% | 1.7B | |
| -26.15% | 384M | |
| -81.65% | 216M | |
| -11.06% | 114M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion
